Goodrx Current Deferred Revenue vs Common Stock Shares Outstanding Analysis
GDRX Stock | USD 6.65 0.05 0.75% |
Goodrx HoldingsInc financial indicator trend analysis is much more than just examining Goodrx HoldingsInc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Goodrx HoldingsInc is a good investment. Please check the relationship between Goodrx HoldingsInc Current Deferred Revenue and its Common Stock Shares Outstanding accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx HoldingsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx HoldingsInc guide.
Current Deferred Revenue vs Common Stock Shares Outstanding
Current Deferred Revenue vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Goodrx HoldingsInc Current Deferred Revenue account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Goodrx HoldingsInc's Current Deferred Revenue and Common Stock Shares Outstanding is 0.92. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Goodrx HoldingsInc, assuming nothing else is changed. The correlation between historical values of Goodrx HoldingsInc's Current Deferred Revenue and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Goodrx HoldingsInc are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Current Deferred Revenue i.e., Goodrx HoldingsInc's Current Deferred Revenue and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Goodrx HoldingsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Goodrx HoldingsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx HoldingsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx HoldingsInc guide.At this time, Goodrx HoldingsInc's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.20 in 2024, despite the fact that Tax Provision is likely to grow to (48.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 34.6M | 54.2M | 111.8M | 117.4M | Interest Income | 59K | 9.3M | 29.1M | 30.6M |
Goodrx HoldingsInc fundamental ratios Correlations
Click cells to compare fundamentals
Goodrx HoldingsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Goodrx HoldingsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 386.8M | 1.5B | 1.6B | 1.6B | 1.6B | 1.3B | |
Short Long Term Debt Total | 711.0M | 704.9M | 702.3M | 717.0M | 711.1M | 569.1M | |
Other Current Liab | 12.1M | 30.8M | 43.9M | 39.6M | 64.2M | 35.6M | |
Total Current Liabilities | 33.4M | 59.6M | 81.1M | 76.3M | 122.6M | 71.4M | |
Total Stockholder Equity | (1.1B) | 711.4M | 831.7M | 814.8M | 762.0M | 800.1M | |
Other Liab | 3.0M | 5.8M | 5.4M | 7.6M | 8.7M | 6.3M | |
Net Tangible Assets | (1.4B) | 393.5M | 831.7M | 814.8M | 937.1M | 983.9M | |
Property Plant And Equipment Net | 34.2M | 50.8M | 49.3M | 55.7M | 45.9M | 43.4M | |
Current Deferred Revenue | 3.5M | 6.9M | 6.9M | 7.9M | 7.1M | 5.9M | |
Net Debt | 684.9M | (263.8M) | (238.8M) | (40.1M) | 38.8M | 36.8M | |
Retained Earnings | (1.1B) | (1.4B) | (1.4B) | (1.4B) | (1.5B) | (1.5B) | |
Accounts Payable | 7.9M | 10.3M | 17.5M | 17.7M | 36.3M | 38.1M | |
Cash | 26.1M | 968.7M | 941.1M | 757.2M | 672.3M | 623.3M | |
Non Current Assets Total | 300.2M | 383.7M | 518.8M | 684.9M | 716.0M | 521.7M | |
Non Currrent Assets Other | 1.2M | 2.0M | (34.3M) | (15.0M) | 22.8M | 23.9M | |
Other Assets | 3.4M | 15.1M | 6.0M | 8.2M | 9.4M | 7.6M | |
Long Term Debt | 663.9M | 659.9M | 655.9M | 651.8M | 647.7M | 532.8M | |
Cash And Short Term Investments | 26.1M | 968.7M | 941.1M | 757.2M | 672.3M | 623.3M | |
Net Receivables | 55.5M | 68.7M | 126.4M | 117.1M | 160.0M | 103.2M | |
Good Will | 236.2M | 261.1M | 329.7M | 412.1M | 410.8M | 342.9M | |
Common Stock Shares Outstanding | 385.4M | 391.7M | 400.6M | 412.9M | 410.3M | 433.3M | |
Liabilities And Stockholders Equity | 386.8M | 1.5B | 1.6B | 1.6B | 1.6B | 1.3B | |
Non Current Liabilities Total | 1.4B | 699.2M | 694.8M | 713.5M | 704.3M | 761.8M | |
Capital Lease Obligations | 40.1M | 38.0M | 39.4M | 58.2M | 54.6M | 42.2M | |
Other Current Assets | 12.4M | 46.0M | 29.6M | 45.4M | 40.4M | 32.5M | |
Other Stockholder Equity | 8.8M | 2.1B | 2.2B | 2.3B | 2.2B | 1.6B | |
Total Liab | 1.5B | 758.8M | 775.9M | 789.8M | 826.8M | 813.7M | |
Net Invested Capital | (416.7M) | 1.4B | 1.5B | 1.5B | 1.4B | 899.8M | |
Property Plant And Equipment Gross | 34.2M | 50.8M | 21.6M | 19.8M | 59.6M | 34.3M | |
Total Current Assets | 86.6M | 1.1B | 1.1B | 919.7M | 872.8M | 756.7M | |
Non Current Liabilities Other | 3.0M | 5.8M | 5.1M | 7.6M | 8.2M | 6.1M | |
Net Working Capital | 53.2M | 1.0B | 1.0B | 843.4M | 750.2M | 685.3M | |
Short Term Debt | 10.0M | 11.6M | 12.9M | 11.1M | 15.0M | 12.1M | |
Intangible Assets | 26.4M | 56.7M | 133.8M | 189.9M | 156.3M | 106.6M | |
Property Plant Equipment | 34.2M | 50.8M | 21.6M | 19.8M | 22.8M | 28.0M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx HoldingsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx HoldingsInc guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Goodrx Stock analysis
When running Goodrx HoldingsInc's price analysis, check to measure Goodrx HoldingsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx HoldingsInc is operating at the current time. Most of Goodrx HoldingsInc's value examination focuses on studying past and present price action to predict the probability of Goodrx HoldingsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx HoldingsInc's price. Additionally, you may evaluate how the addition of Goodrx HoldingsInc to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Goodrx HoldingsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Goodrx HoldingsInc. If investors know Goodrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Goodrx HoldingsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.635 | Earnings Share (0.02) | Revenue Per Share 1.829 | Quarterly Revenue Growth 0.068 | Return On Assets 0.0195 |
The market value of Goodrx HoldingsInc is measured differently than its book value, which is the value of Goodrx that is recorded on the company's balance sheet. Investors also form their own opinion of Goodrx HoldingsInc's value that differs from its market value or its book value, called intrinsic value, which is Goodrx HoldingsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Goodrx HoldingsInc's market value can be influenced by many factors that don't directly affect Goodrx HoldingsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Goodrx HoldingsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Goodrx HoldingsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Goodrx HoldingsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.